- Home
- MSB vs PACB Comparison
MSB vs PACB Comparison
Compare MSB & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSB
- PACB
- Stock Information
- Founded
- MSB 1961
- PACB 2000
- Country
- MSB United States
- PACB United States
- Employees
- MSB N/A
- PACB N/A
- Industry
- MSB Metal Mining
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- MSB Basic Materials
- PACB Industrials
- Exchange
- MSB Nasdaq
- PACB Nasdaq
- Market Cap
- MSB 320.9M
- PACB 364.2M
- IPO Year
- MSB N/A
- PACB 2010
- Fundamental
- Price
- MSB $25.99
- PACB $1.37
- Analyst Decision
- MSB
- PACB Buy
- Analyst Count
- MSB 0
- PACB 9
- Target Price
- MSB N/A
- PACB $2.06
- AVG Volume (30 Days)
- MSB 33.9K
- PACB 9.3M
- Earning Date
- MSB 01-01-0001
- PACB 08-06-2025
- Dividend Yield
- MSB 26.70%
- PACB N/A
- EPS Growth
- MSB 335.65
- PACB N/A
- EPS
- MSB 7.12
- PACB N/A
- Revenue
- MSB $25,894,592.00
- PACB $152,357,000.00
- Revenue This Year
- MSB N/A
- PACB $3.33
- Revenue Next Year
- MSB N/A
- PACB $17.88
- P/E Ratio
- MSB $3.61
- PACB N/A
- Revenue Growth
- MSB N/A
- PACB N/A
- 52 Week Low
- MSB $15.93
- PACB $0.85
- 52 Week High
- MSB $37.00
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- MSB 56.61
- PACB 52.51
- Support Level
- MSB $24.00
- PACB $1.36
- Resistance Level
- MSB $25.67
- PACB $1.62
- Average True Range (ATR)
- MSB 0.79
- PACB 0.11
- MACD
- MSB 0.23
- PACB -0.01
- Stochastic Oscillator
- MSB 93.06
- PACB 41.98
About MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.